Immune
NAD+
Nicotinamide Adenine Dinucleotide
Scientific Overview
NAD+ is a central redox coenzyme. Research interest focuses on NAD+-boosting strategies (e.g., nicotinamide riboside, NMN) for aging biology, mitochondrial function, and metabolic resilience.
Mechanism focus: Supports sirtuin and PARP enzymatic activity; precursor supplementation can raise blood and tissue NAD+ metabolomes in human studies.
Research Use Cases
- NAD+ metabolome quantification
- Aging and senescence pathway research
- Skeletal-muscle bioenergetics studies
- Safety/tolerability of NAD precursors in humans
Use-Case Study Notations
- Case-study notation: chronic nicotinamide riboside raised NAD+ in healthy middle-aged/older adults with good tolerability.
- Case-study notation: aged skeletal-muscle studies show NR can augment the NAD+ metabolome.
- NAD+ itself differs from peptide APIs—handle analytical methods accordingly.
Selected Studies (English, PubMed)
Five peer-reviewed sources indexed on PubMed. Links open the PubMed record for verification.
- Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults — PubMed 29599478
- Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) — PubMed 31278280
- Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome — PubMed 31412242
- Nicotinamide riboside is uniquely and orally bioavailable in mice and humans — PubMed 27721479
- Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions — PubMed 37068054
Related compounds
Research Use Only. This page is educational and intended for laboratory research context. Products are not for human consumption and are not intended to diagnose, treat, cure, or prevent any disease.